MedPath

费森尤斯卡比(广州)医疗用品有限公司

Ownership
-
Established
1995-02-25
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

33

NMPA:33

Drug Approvals

Anticoagulation Solution Ⅲ

Product Name
血液保存液Ⅲ
Approval Number
国药准字H20044484
Approval Date
Jan 15, 2020
NMPA

Anticoagulation Solution Ⅲ

Product Name
血液保存液Ⅲ
Approval Number
国药准字H20033739
Approval Date
Jan 15, 2020
NMPA

Anticoagulation Solution Ⅲ

Product Name
血液保存液Ⅲ
Approval Number
国药准字H20044482
Approval Date
Jan 15, 2020
NMPA

Anticoagulation Solution Ⅲ

Product Name
血液保存液Ⅲ
Approval Number
国药准字H20044483
Approval Date
Jan 15, 2020
NMPA

Anticoagulant Solution Ⅱ

Product Name
血液保存液(Ⅱ)
Approval Number
国药准字H20044481
Approval Date
Jan 15, 2020
NMPA

Anticoagulant Solution Ⅱ

Product Name
血液保存液(Ⅱ)
Approval Number
国药准字H20033741
Approval Date
Jan 15, 2020
NMPA

Anticoagulation Solution Ⅲ

Product Name
血液保存液Ⅲ
Approval Number
国药准字H20033740
Approval Date
Jan 15, 2020
NMPA

Red cell Storaging Solution

Product Name
红细胞保存液
Approval Number
国药准字H20033706
Approval Date
Jan 15, 2020
NMPA

Red cell Storaging Solution

Product Name
红细胞保存液
Approval Number
国药准字H20033708
Approval Date
Jan 15, 2020
NMPA

Sodium chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20034110
Approval Date
Oct 24, 2019
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.